Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF) | MicrobiomeTrials← Back to trialsNCT07711938
Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2028-07-31
Enrollment target: 410 participants Other microbiome trials you might be interested in
Allergy and ImmunologyPeanut and Nut AllergyEgg AllergyFood Allergy in InfantsFood Allergy Peanut
Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two…
Rochester, United StatesEst. completion Jun 2028
Infant Nutritional Physiological PhenomenaInfant FormulaInfant HealthInfant DevelopmentGrowth and Development
This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tol…
Cavite City, PhilippinesEst. completion Dec 2027